Archives

by in
Entry Author Date Location
GlobeImmune Cuts Size of Pending IPO by 29 Percent 05/22/14 Boulder/Denver
GlobeImmune Sets $15 to $17 Price Range in Second IPO Attempt 04/29/14 Boulder/Denver
Proteostasis, Biogen Team up on Protein Homeostasis Drugs 12/09/13 Boston
PathoGenetix Garners $10,000,000 Series C Financing Round 10/30/13 Boston
Theraclone Secures $14M to Push Antibody Drug Programs 03/25/13 Seattle
Theraclone Sciences Receives $14,000,000 Series B Funding Round 03/25/13 Seattle
Theraclone Sciences Garners $14,000,000 Series B Financing 03/25/13 Seattle
DecImmune Therapeutics Garners $2,250,000 Series A Financing Round 01/17/13 Boston
Vaxxas Entices Merck to Try Needle-Free Vaccine Technique 10/08/12 Boston
Who’s Still Active Among the Early-Stage Biotech VCs? 07/02/12 National
Promedior Moves Fibrosis Pipeline to Boston, Hires Shire Vet as CEO 05/15/12 Boston
Radius Health Seeks $86M IPO 02/07/12 Boston
PathoGenetiX Secures $7,500,000 Series B Financing 11/01/11 Boston
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News 10/14/11 Boston
Report: Tolerx Folds Its Tent, After $150M in Investment and a Failed Diabetes Drug Trial 10/07/11 Boston
Tensha Nabs $15M, Termeer Gives MIT $10M, Stata Puts $10M Into NABsys, & More Boston-Area Life Sciences News 09/16/11 Boston
PerkinElmer Acquires Caliper for $600M, VideoIQ Nabs $7.5M, MC10 Snags $2.5M, & More Boston-Area Deals News 09/14/11 Boston
Tensha Therapeutics Receives $15,000,000 Series A Financing Round 09/13/11 Boston
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
Theraclone Sciences Secures $10,600,000 Series B Round 09/08/11 Seattle
Cleveland Heartlab Lands $18,400,000 Series B Financing Round 08/22/11 Detroit
Mosaic Biosciences Secures $1,030,462 Series A Funding 07/22/11 Boulder/Denver
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs 05/25/11 Boston
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing 05/24/11 Boston
Radius Health Obtains $91,000,000 New Funding 05/24/11 Boston
Proteostasis Adds Targets, Drugs From Harvard 04/26/11 Boston
Tolerx and Glaxo Diabetes Drug Disappoints in Late-Stage Study 03/11/11 Boston
EnerNOC Acquires M2M, H3 Launches With Eisai Funding, Genzyme Talks With Sanofi Advance, & More Boston-Area Deals News 02/02/11 Boston
CloudTP Comes Out of Stealth, With $1M in Equity Seed Funding, to Help Big Companies Move Data to Their Own Private Clouds 01/31/11 Boston
Top 10 List of Boston-Area VC Deals for Q4 2010: NinePoint, 1366, Rive, and More 01/24/11 Boston
Page 1 of 4 next page »